Table 3. Comparison of short-term oncological outcomes between conventional APER and ELAPER.
Oncological outcomes | Conventional (n=78), n [%] | ELAPER (n=42), n [%] | P |
---|---|---|---|
CRM involvement | 7 [8.9] | 3 [7.14] | 1 |
Tumor site perforation | 0.529 | ||
No | 75 [96.16] | 39 [92.86] | |
Yes | 3 [3.84] | 3 [7.14] | |
Nodes (median) | 11 | 8 | 0.481 |
pT | 0.798 | ||
No residual tumor | 17 [22] | 9 [21] | |
T1 | 6 [8] | 1 [3] | |
T2 | 20 [25] | 13 [31] | |
T3 | 31 [40] | 16 [38] | |
T4 | 4 [5] | 3 [7] |
APER, abdominoperineal resection; ELAPER, extralevator APER; CRM, circumferential resection margin; pT, pathological tumor stage.